Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B Patients

NCT01997944 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

BIOLOGICAL: Human Serum ALbumin/interferon alpha2a
BIOLOGICAL: Pegasys

Sponsor

Beijing Bio-Fortune Ltd.